The new wave of cancer vaccines and therapies

2026-10-27T00:42:17.000Z A landmark trial found a melanoma vaccine cut recurrence or death risk by 42%, joining personalized vaccines for kidney cancer and the 'deadliest major cancer', plus reprogrammed immune cells that cleared a child's cancer. Read on below, and follow ScienceAlert for more cancer research news.